Cite

HARVARD Citation

    Rosenberg, T. et al. (2022). Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma. Neuro-oncology. 24 (11), pp. 1964-1975. [Online]. 
  
Back to record